What Upcoming Part D Changes Could Mean for Medicare Beneficiaries | AMCP Nexus 2024
Crescent Moore, Ph.D., Pharm.D., Director of Part D/Pharmacy at BluePeak Advisors, explains the impacts of the upcoming changes to Medicare Part D.
“For 2025, as part of the Part D redesign, we have three major changes to the Part D benefit,” Crescent Moore, Ph.D., Pharm.D., Director of Part D/Pharmacy, BluePeak Advisors. “The first is going to be that $2,000 out of pocket limit that the beneficiaries that will have that we've all heard so much about. The second is the closing of the coverage gap. The third is the Medicare Prescription payment plan.”
Beneficiaries who choose the payment plan will pay nothing at the time of pickup and then get a bill in the mail later. Payments will be spread out over the course of the year. Moore said beneficiaries with high drug costs at the beginning of the year would benefit most from this program.
Moore spoke today at AMCP Nexus 2024 held at the MGM Grand in Las Vegas. She co-led the session called, ‘CY 2025 Medicare Part D Redesign: A Medicare Odyssey.’
BluePeak Advisors is a consulting division of Gallagher Benefit Services, Inc., and specializes in Medicare.
With New Drugs in the Offing, Treatment Cost of ATTR-CM Is Projected to Climb | AMCP Nexus 2024
October 16th 2024Several companies are developing new drugs to treat transthyretin amyloidosis cardiomyopathy (ATTR-CM), a formerly obscure condition that is getting an increasing amount of attention.
Read More
Health Plans Embrace Biosimilars to Reduce Costs and Improve Patient Access | AMCP Nexus 2024
October 16th 2024How health plans are implementing strategies to leverage biosimilars to lower costs for both payers and patients, according to Javier Gonzalez, Pharm.D., chief growth and commercial officer of Abarca
Read More
